People: DarioHealth Corp (DRIO.OQ)

DRIO.OQ on NASDAQ Stock Exchange Capital Market

1:30am IST
Change (% chg)

$-1.32 (-7.72%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Anderson, Richard 

Mr. Richard Allan Anderson serves as President, General Manager - North America of the Company. Mr. Jarry has served on our Advisory Board and as a Strategic Advisory consultant since 2017. From November 2003 to December 2019, Mr. Anderson worked for Catasys, Inc. (Nasdaq: CATS), where he served as President and Chief Operating Officer from July 2008 to December 2019, and as a member of its board of directors from November 2003 to July 2019. Prior to Catasys, Inc., Mr. Anderson served as Senior Executive Vice President of Hythiam, Inc., a predecessor company of Catasys, Inc., from 2005 to 2008. From 1999 to 2005, he also served as Chief Financial Officer and Secretary of Clearant, Inc., a biotechnology company. Prior to Clearant, from 1999 to 2001, he served as the Chief Financial Officer and Managing Director of Intellect Capital Group, a venture consulting firm. Earlier in his career, Mr. Anderson was a Senior Manager/Director for Price Waterhouse Cooper. Mr. Anderson holds a B.A. in Business Economics from the University of California at Santa Barbara.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Yoav Shaked


Richard Anderson


Erez Raphael


Zvi Ben-David


Dror Bacher


Olivier Jarry

As Of  31 Dec 2019